Kerry Eardley

Kerry Eardley is an accomplished finance professional with extensive experience in financial strategy, audit, and controllership roles. As Associate Director of Finance and Portfolio Strategy for Takeda's Global Plasma-Derived Therapies Business Unit since November 2014, Kerry plays a pivotal role in financial planning and performance analysis. Previously, Kerry served as Associate Director of Financial Controlling Business Partner for the Europe and Canada Business Unit, overseeing financial controls and risk management across 27 commercial entities. Kerry's background in internal audit at Takeda and Shire Pharmaceuticals includes leading numerous financial and compliance audits. Prior to joining Takeda, Kerry worked at World Fuel Services as a Senior Accountant, handling the preparation of financial statements, and at KPMG, providing professional audit services across various industries. Kerry holds a Bachelor of Science in Accounting and Finance from Indiana University Bloomington.